Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 40133-22-0 | MDL No. : | MFCD05664340 |
Formula : | C10H7BrS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XKOJJKOSNQXQGP-UHFFFAOYSA-N |
M.W : | 239.13 | Pubchem ID : | 7018298 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 57.46 |
TPSA : | 28.24 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.61 cm/s |
Log Po/w (iLOGP) : | 2.69 |
Log Po/w (XLOGP3) : | 4.43 |
Log Po/w (WLOGP) : | 4.18 |
Log Po/w (MLOGP) : | 3.65 |
Log Po/w (SILICOS-IT) : | 4.9 |
Consensus Log Po/w : | 3.97 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.73 |
Solubility : | 0.0045 mg/ml ; 0.0000188 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.74 |
Solubility : | 0.00434 mg/ml ; 0.0000181 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.04 |
Solubility : | 0.00217 mg/ml ; 0.00000908 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 1.95 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74.6% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In tetrahydrofuran; water; toluene for 5 h; Reflux | A mixture of 1-bromo-4-iodobenzene (2.0 g, 7.07 mmol), 4,4,5,5-tetramethyl-2-(thiophen-2-yl)-1,3,2-dioxaborolane (2.97 g, 14.1 mmol), Pd(PPh34 (408 mg, 0.35 mmol), and Na2CO3 (1.49 g, 14.1 mmol) were dissolved in toluene (40 mL), THF (15 mL), and H2O (15 mL) and the reaction mixture was refluxed for 5 h. After completion of the reaction (indicated by TLC), the solvent was removed under vacuum, H2O (30 mL) and CH2Cl2 (40 mL) were added. The organic layer was separated and dried on anhydrous MgSO4. The solvent was removed under reduced pressure. Then the crude product was purified by flash column chromatography on silica gel to give 2-(4-bromophenyl) thiophene (1.26 g, 74.6percent). Spectral data matched well with values reported in the literature.27 1HNMR (400 MHz, CDCl3: 7.48 (d, 3.6 Hz, 4 H), 7.29(d, 4.4 Hz, 2 H), 7.07 (dt, 1.4, 4.4 Hz, 1 H). |
[ 118621-30-0 ]
2-(4-Bromophenyl)-5-phenylthiophene
Similarity: 0.98
[ 960203-41-2 ]
(2-Bromophenyl)(2,4-dimethylphenyl)sulfane
Similarity: 0.86
[ 1030825-20-7 ]
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
Similarity: 0.80
[ 70398-89-9 ]
1-Bromo-4-(propan-2-ylsulfanyl)benzene
Similarity: 0.72
[ 1034305-17-3 ]
2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene
Similarity: 0.71
[ 118621-30-0 ]
2-(4-Bromophenyl)-5-phenylthiophene
Similarity: 0.98
[ 83834-10-0 ]
3,7-Dibromodibenzo[b,d]thiophene
Similarity: 0.88
[ 960203-41-2 ]
(2-Bromophenyl)(2,4-dimethylphenyl)sulfane
Similarity: 0.86